Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-019498 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
10,612
Total Value
$396,610.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Mar 16, 2026 | Sale | 6,371 | $37.11 | $236,427.81 | 141,342 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Mar 16, 2026 | Sale | 4,241 | $37.77 | $160,182.57 | 137,101 | Direct | โ | View Details |